Heterogeneity and clinical role of thymidine phosphorylase activity in gastric cancer

被引:2
|
作者
Kakeji, Y [1 ]
Maehara, Y
Shibahara, K
Hasuda, S
Oshiro, T
Baba, H
Kohnoe, S
Sugimachi, K
机构
[1] Kyushu Univ, Fac Med, Dept Surg 2, Higashi Ku, Fukuoka 8128582, Japan
[2] Kyushu Natl Canc Ctr, Dept Surg Gastroenterol, Fukuoka, Japan
关键词
thymidine phosphorylase; gastric cancer; heterogeneity; lymph node metastasis;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We examined the dThdPase activity in primary gastric cancer and metastatic lymph nodes from human subjects. The dThdPase activities were significantly higher in primary tumors than in the normal gastric wall, particularly in the center of the tumor rather than in the periphery (P<0.01). Tumors with a high dThdPase activity often had venous invasion (P<0.01). The dThdPase activities were significantly higher in metastatic lymph nodes than in the nodes without metastasis (P<0.01). The intratumoral heterogeneity of dThdPase activity was identified and cancer cells with high dThdPase activity may indicate that metastasis will likely occur.
引用
收藏
页码:1213 / 1216
页数:4
相关论文
共 50 条
  • [21] Clinical significance of the detection of thymidine phosphorylase activity in esophageal squamous cell carcinomas
    Ikeguchi, M
    Oka, S
    Saito, H
    Kondo, A
    Tsujitani, S
    Maeta, M
    Kaibara, N
    EUROPEAN SURGICAL RESEARCH, 1999, 31 (04) : 357 - 363
  • [22] Thymidine phosphorylase expression in gastric carcinoma as a marker for metastasis
    Konno, S
    Takebayashi, Y
    Higashimoto, M
    Katsube, T
    Kanzaki, A
    Kawahara, M
    Takenoshita, S
    Aiba, M
    Ogawa, K
    ANTICANCER RESEARCH, 2003, 23 (6D) : 5011 - 5014
  • [23] Measurement of serum thymidine phosphorylase levels by highly sensitive enzyme-linked immunosorbent assay in gastric cancer
    Katayanagi, S
    Aoki, T
    Takagi, Y
    Ito, K
    Sudo, H
    Tsuchida, A
    Koyanagi, Y
    ONCOLOGY REPORTS, 2003, 10 (01) : 115 - 119
  • [24] Prediction of the effect of capecitabine in gastric cancer by immunohistochemical staining of thymidine phosphorylase and dihydropyrimidine dehydrogenase
    Koizumi, Wasaburo
    Okayasu, Isao
    Hyodo, Ichinosuke
    Sakamoto, Junichi
    Kojima, Hiroshi
    ANTI-CANCER DRUGS, 2008, 19 (08) : 819 - 824
  • [25] RADIOSENSITIZATION BY THYMIDINE PHOSPHORYLASE INHIBITOR IN THYMIDINE PHOSPHORYLASE NEGATIVE AND OVEREXPRESSING BLADDER CANCER CELL LINES
    El-Naggar, Maha
    Ebbing, Eva
    Bijnsdorp, Irene
    van den Berg, Jaap
    Peters, Godefridus J.
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2014, 33 (4-6) : 413 - 421
  • [26] The ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase in tumour tissues of patients with metastatic gastric cancer is predictive of the clinical response to 5′-deoxy-5-fluorouridine
    Nishina, T
    Hyodo, I
    Miyaike, J
    Inaba, T
    Suzuki, S
    Shiratori, Y
    EUROPEAN JOURNAL OF CANCER, 2004, 40 (10) : 1566 - 1571
  • [27] Gastric Cancer Heterogeneity and Clinical Outcomes
    Sexton, Rachel E.
    Al Hallak, Mohammed Najeeb
    Uddin, Md. Hafiz
    Diab, Maria
    Azmi, Asfar S.
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2020, 19
  • [28] Making Capecitabine Targeted Therapy for Breast Cancer: Which is the Role of Thymidine Phosphorylase?
    Bonotto, Marta
    Bozza, Claudia
    Di Loreto, Carla
    Osa, Etin-Osa O.
    Poletto, Elena
    Puglisi, Fabio
    CLINICAL BREAST CANCER, 2013, 13 (03) : 167 - 172
  • [29] The role of thymidine phosphorylase/PD-ECGF in cancer chemotherapy: a chemical perspective
    Cole, C
    Foster, AJ
    Freeman, S
    Jaffar, M
    Murray, PE
    Stratford, IJ
    ANTI-CANCER DRUG DESIGN, 1999, 14 (05): : 383 - 392
  • [30] Comparative analysis of thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in gastric and colorectal cancers
    Hotta, T
    Taniguchi, K
    Kobayashi, Y
    Johata, K
    Sahara, M
    Naka, T
    Watanabe, T
    Ochiai, M
    Tanimura, H
    Tsubota, YT
    ONCOLOGY REPORTS, 2004, 11 (05) : 1045 - 1051